← Back to Search

Other

Fertility Supplement for Male Infertility (FertEnhancer Trial)

Phase 2
Waitlist Available
Research Sponsored by Hamilton Health Sciences Corporation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 3 months
Awards & highlights

FertEnhancer Trial Summary

This trial will test if a novel multi-ingredient supplement can improve male fertility by targeting age-related cell pathways.

Who is the study for?
Men aged 25-50 with diagnosed subfertility can join this trial. They must meet WHO criteria for sperm health but cannot have genital diseases, recent reproductive surgeries, or be using certain medications like immunosuppressants. Smokers and those with a BMI over 30 aren't eligible.Check my eligibility
What is being tested?
The study is testing a new multi-ingredient supplement (Fertility Enhancer) against a placebo to see if it improves sperm function in subfertile men by targeting oxidative stress and other age-related cell issues over three months.See study design
What are the potential side effects?
Potential side effects are not specified here, but supplements could cause allergic reactions, gastrointestinal discomfort or interact with other medications.

FertEnhancer Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Percent change in body composition index from baseline to 3 months
Percent change in sperm count/concentration from baseline to 3 months
Percent change in sperm morphology from baseline to 3 months
+3 more
Secondary outcome measures
Percent change in sperm ATP levels from baseline to 3 months
Percent change in sperm DNA 8-hydroxydeoxyguanosine from baseline to 3 months
Percent change in sperm DNA fragmentation index from baseline to 3 months
+16 more
Other outcome measures
Percent change in ATP levels from baseline to 3 months
Percent change in Oxygen Radical Absorbance Levels (ORAC) from baseline to 3 months
Percent change in Trolox Equivalent Antioxidant Capacity (TEAC) from baseline to 3 months
+14 more

FertEnhancer Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Active multi-ingredient supplement (Fertility Enhancer; FE)Experimental Treatment1 Intervention
Volunteers will be randomized in a double-blinded fashion into the experimental treatment group, which entails daily supplementation of an active multi-ingredient supplement designed to enhance fertility (Fertility Enhancer; FE) for 3 months.
Group II: Inactive placebo (Placebo; PLA)Placebo Group1 Intervention
Volunteers will be randomized in a double-blinded fashion into a placebo group, which entails daily supplementation of a calorie-matched, inactive placebo (Placebo; PLA) identical in flavor to the active supplement for 3 months.

Find a Location

Who is running the clinical trial?

One FertilityOTHER
3 Previous Clinical Trials
530 Total Patients Enrolled
Hamilton Health Sciences CorporationLead Sponsor
368 Previous Clinical Trials
300,902 Total Patients Enrolled
~37 spots leftby Feb 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top